Business Combinations (Tables) (Gen-Probe Incorporated [Member])

3 Months Ended

Dec. 29, 2012

Gen-Probe Incorporated [Member]

Purchase Price Consideration

The purchase price consideration was as follows:

Cash paid	$	3,967,866
Deferred payment		1,655
Fair value of stock options exchanged		2,655
Total purchase price	$	3,972,176

Components of Purchase Price Allocation

The components of the preliminary purchase price allocation are as follows:

Cash	$	205,463
Accounts receivable		80,301
Inventory		153,416
Property, plant and equipment		274,095
Other assets		191,868
Assets held-for-sale, net		87,465
Accounts payable		(19,671	)
Accrued expenses		(131,102	)
Other liabilities		(19,255	)
Identifiable intangible assets:
Developed technology		1,565,000
In-process research and development		227,000
Customer contract		585,000
Trade names		95,000
Deferred income taxes, net		(973,524	)
Goodwill		1,651,120
Purchase Price	$	3,972,176

Assets Groups Classified as Held-For-Sale

The following represents the components of the asset groups classified as held-for-sale as of December 29, 2012:

Assets:
Cash	$	2,272
Accounts receivable		7,549
Inventory		14,469
Property and equipment		13,431
Other assets		1,851
Intangible assets and goodwill		51,880
Total assets held-for-sale	$	91,452
Liabilities:
Accrued liabilities		(7,403	)
Net assets held-for-sale	$	84,049

Schedule of Unaudited Pro Forma Information, Assumptions

The following unaudited pro forma information presents the combined financial results for the Company and Gen-Probe as if the acquisition of Gen-Probe had been completed as of the beginning of the fiscal year prior to the period of acquisition, September 26, 2010:

	Three Months Ended December 24, 2011
Revenue	$	630,844
Net loss	$	(10,195	)
Basic and diluted net loss per common share	$	(0.04	)